Cargando…

SARS-CoV-2, COVID-19 and Neurodegeneration

Detalles Bibliográficos
Autores principales:	Tönges, Lars, Klebe, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312886/ https://www.ncbi.nlm.nih.gov/pubmed/35884704 http://dx.doi.org/10.3390/brainsci12070897

Ejemplares similares

SARS-CoV-2, COVID-19 and Parkinson’s Disease—Many Issues Need to Be Clarified—A Critical Review
por: Goerttler, Tsepo, et al.
Publicado: (2022)

SARS‐CoV‐2, aging, and Post‐COVID‐19 neurodegeneration
por: Strong, Michael J.
Publicado: (2022)

Focus on SARS-CoV-2 and COVID-19
por: Chen, Sharon C-A., et al.
Publicado: (2020)

SARS-CoV-2, long COVID, prion disease and neurodegeneration
por: Zhao, Yuhai, et al.
Publicado: (2022)

Airborne transmission of SARS-CoV-2 disease (COVID-19)
por: Parvez, Mohammad K, et al.
Publicado: (2022)

Nutrition support in the time of SARS-CoV-2 (COVID-19)
por: Laviano, Alessandro, et al.
Publicado: (2020)

The global battle against SARS-CoV-2 and COVID-19
por: Deng, Chu-Xia
Publicado: (2020)

Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients
por: Cipollaro, Lucio, et al.
Publicado: (2020)

The cardiac effects of SARS-CoV2: COVID-19 special issue
por: Camm, C Fielder, et al.
Publicado: (2020)

Hospital biopreparedness in the Looming Presence of SARS‐CoV‐2/COVID‐19
por: Popescu, Saskia
Publicado: (2020)

SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
por: Baldo, Vincenzo, et al.
Publicado: (2021)

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
por: Parums, Dinah V.
Publicado: (2021)

The continued global battle against SARS-CoV-2 and COVID-19
por: Deng, Chu-Xia
Publicado: (2021)

Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
por: Saxena, Shailendra K., et al.
Publicado: (2020)

Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration?
por: Young, Michael J., et al.
Publicado: (2020)

SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies
por: Putilina, M. V., et al.
Publicado: (2021)

Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2
por: Baig, Abdul Mannan
Publicado: (2020)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

SARS-CoV-2 docet
por: Sarli, Leopoldo
Publicado: (2021)

The global battle against SARS-CoV-2 and COVID-19 at the third year
por: Deng, Chu-Xia
Publicado: (2022)

SARS CoV-2 (COVID-19): lessons to be learned by Brazilian Physical Therapists
por: Pinto, Thiago Fernandes, et al.
Publicado: (2020)

COVID-19 Gastrointestinal Symptoms and Attenuation of the Immune Response to SARS-CoV-2
por: Miller, Jonathan, et al.
Publicado: (2021)

SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
por: Zhao, Yuhai, et al.
Publicado: (2022)

Monogenetic Forms of Parkinson’s Disease – Bridging the Gap Between Genetics and Biomarkers
por: Tönges, Lars, et al.
Publicado: (2022)

GI-COVID: Are There COVID-19 Patients with Primary Gastrointestinal SARS-CoV-2 Infection and Symptoms?
por: Ong, John, et al.
Publicado: (2021)

Fighting the SARS-CoV-2 Pandemic: Focusing a New Lens on COVID-19
por: Wang, Fudi
Publicado: (2022)

Understanding Molecular Actors of SARS-CoV-2 Virulence to Tackle COVID-19 Outbreak
por: Berisio, Rita
Publicado: (2022)

Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19
por: Bose, Rajendran J.C., et al.
Publicado: (2020)

The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2
por: Barth, Rolf F., et al.
Publicado: (2020)

Preoperative SARS-CoV-2 screening: Can it really rule out COVID-19?
por: Lother, Sylvain A.
Publicado: (2020)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

SARS-CoV-2 reinfection: “New baseline” imaging concept in the era of COVID-19
por: Katal, Sanaz, et al.
Publicado: (2021)

Diabetes, SARS-CoV-2/COVID-19 vaccines and glycemic control: Call for data
por: Ceriello, Antonio
Publicado: (2021)

A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
por: Chavda, Vivek P, et al.
Publicado: (2021)

Special issue editorial: Methods to facilitate SARS-CoV-2 and COVID-19 research
por: Gagnon, Keith T, et al.
Publicado: (2021)

Tracking the progress of inequalities in SARS-CoV-2 infections into the third covid-19 wave
por: Chilunga, Felix P, et al.
Publicado: (2023)

Fundamentals of SARS-CoV-2 Biosensors
por: Torres-Torres, Carlos, et al.
Publicado: (2022)

Terrific cells for SARS-CoV-2
por: Gottschalk, Stephen
Publicado: (2022)

Is the Patient Infected with SARS-CoV-2?
por: Klausner, Jeffrey D., et al.
Publicado: (2021)

Sowing SARS-CoV-2 to reap neurodegeneration: A hamster study
por: Rasika, S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k75tbfh3sebus0kve4hpn1rcao